Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Rockman

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Virology|January 4, 2013
Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccineSteven Rockman, Lorena E Brown, Ian G Barr, et al.
The Journal of Infectious Diseases|September 30, 2010
A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adultsKawsar R Talaat, Michael E Greenberg, Michael H Lai, et al.
Biotechnology and Bioengineering|February 12, 2025
Development of Methods to Produce SARS CoV-2 Virus-Like Particles at ScaleMelissa A Edeling, Linda Earnest, Julio Carrera Montoya, et al.
Ebiomedicine|July 19, 2016
What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus ProteinsHillary A Vanderven, Fernanda Ana-Sosa-Batiz, Sinthujan Jegaskanda, et al.
Vaccine|June 21, 2023
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccineAleksei Ekimov, Arun B Arunachalam, Taylor Blake, et al.
Vaccine|September 6, 2016
Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trialWilliam J H Mcbride, Walter P Abhayaratna, Ian Barr, et al.
JCI Insight|January 9, 2025
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccinesWen Shi Lee, Kevin J Selva, Jennifer Audsley, et al.
EMBO Molecular Medicine|March 10, 2026
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccinationWuji Zhang, E Kaitlynn Allen, Shihan Li, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Virology|January 4, 2013
Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccineSteven Rockman, Lorena E Brown, Ian G Barr, et al.
The Journal of Infectious Diseases|September 30, 2010
A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adultsKawsar R Talaat, Michael E Greenberg, Michael H Lai, et al.
Biotechnology and Bioengineering|February 12, 2025
Development of Methods to Produce SARS CoV-2 Virus-Like Particles at ScaleMelissa A Edeling, Linda Earnest, Julio Carrera Montoya, et al.
Ebiomedicine|July 19, 2016
What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus ProteinsHillary A Vanderven, Fernanda Ana-Sosa-Batiz, Sinthujan Jegaskanda, et al.
Vaccine|June 21, 2023
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccineAleksei Ekimov, Arun B Arunachalam, Taylor Blake, et al.
Vaccine|September 6, 2016
Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trialWilliam J H Mcbride, Walter P Abhayaratna, Ian Barr, et al.
JCI Insight|January 9, 2025
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccinesWen Shi Lee, Kevin J Selva, Jennifer Audsley, et al.
EMBO Molecular Medicine|March 10, 2026
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccinationWuji Zhang, E Kaitlynn Allen, Shihan Li, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
Pageof 5